These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9617943)

  • 1. Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part I: oxygen uptake in tubular vessels.
    Patel S; Mehra A
    ASAIO J; 1998; 44(3):144-56. PubMed ID: 9617943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part II: tissue oxygenation.
    Patel S; Mehra A
    ASAIO J; 1998; 44(3):157-65. PubMed ID: 9617944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced oxygen delivery induced by perfluorocarbon emulsions in capillary tube oxygenators.
    Vaslef SN; Goldstick TK
    ASAIO J; 1994; 40(3):M643-8. PubMed ID: 8555593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood.
    Shah N; Mehra A
    ASAIO J; 1996; 42(3):181-9. PubMed ID: 8725685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free energy reduction by molecular interface crossing: novel mechanism for the transport of material across the interface of nanoscale droplets induced by competing intermolecular forces for application in perfluorocarbon blood substitutes.
    Sommer AP; Röhlke W; Franke RP
    Naturwissenschaften; 1999 Jul; 86(7):335-9. PubMed ID: 10451857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen delivery from fluorocarbon emulsions--aspects of convective and diffusive transport.
    Faithfull NS
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):797-804. PubMed ID: 1391514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(1):47-63. PubMed ID: 15768565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluorocarbon emulsions and cardiopulmonary bypass: a technique for the future.
    Spiess BD; Cochran RP
    J Cardiothorac Vasc Anesth; 1996 Jan; 10(1):83-89; quiz 89-90. PubMed ID: 8634391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of newly developed perfluorocarbon emulsion: oxygen carrying capacity as the blood substitute in vivo.
    Sakanoue J; Tamura M; Fukushima S; Takeuchi Y; Sakuma I; Kitabatake A
    Artif Cells Blood Substit Immobil Biotechnol; 2001 Sep; 29(5):389-97. PubMed ID: 11708662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluorocarbon-based oxygen carriers: from physics to physiology.
    Jägers J; Wrobeln A; Ferenz KB
    Pflugers Arch; 2021 Feb; 473(2):139-150. PubMed ID: 33141239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rheological behavior of blood substitutes with a perfluorocarbon base].
    Draffehn J; Reichelt H
    Pharmazie; 1991 Nov; 46(11):800-2. PubMed ID: 1725823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the perfluorocarbon emulsions of second generation.
    Meinert H; Fackler R; Knoblich A; Mader J; Reuter P; Röhlke W
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):805-18. PubMed ID: 1391515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes.
    Flaim SF
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1043-54. PubMed ID: 7849908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a 3D volume 19F MR imaging protocol for mapping oxygen tension (pO2) in perfluorocarbons at low field.
    Pratt RG; Zheng J; Stewart BK; Shiferaw Y; McGoron AJ; Samaratunga RC; Thomas SR
    Magn Reson Med; 1997 Feb; 37(2):307-13. PubMed ID: 9001157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluorocarbon emulsion improves oxygen transport of normal and sickle cell human blood in vitro.
    Torres Filho IP; Pedro JR; Narayanan SV; Nguyen NM; Roseff SD; Spiess BD
    J Biomed Mater Res A; 2014 Jul; 102(7):2105-15. PubMed ID: 23894124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorocarbon-based oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):567-80. PubMed ID: 17090429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorocarbon-based red blood cell substitutes.
    Biro GP
    Transfus Med Rev; 1993 Apr; 7(2):84-95. PubMed ID: 8481603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluorocarbon emulsions increase transfer of oxygen in plasma from erythrocyte to tissues.
    Perevedentseva EV; Zaritskiy AR; Fok MV; Kuznetsova IN
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Mar; 26(2):223-9. PubMed ID: 9564440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro model to compare the oxygen offloading behaviour of dodecafluoropentane emulsion (DDFPe).
    Jayaraman MS; Graham K; Unger EC
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):783-789. PubMed ID: 30873883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemorheological implications of perfluorocarbon based oxygen carrier interaction with colloid plasma expanders and blood.
    Vásquez DM; Ortiz D; Alvarez OA; Briceño JC; Cabrales P
    Biotechnol Prog; 2013; 29(3):796-807. PubMed ID: 23606592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.